LEADER 01933nas  2200589-a 450 
001 996335979603316
005 20230227213019.0
011   $a1531-6904
035   $a(OCoLC)42429747
035   $a(CKB)110980865608966
035   $a(CONSER)---00208326-
035   $a(EXLCZ)99110980865608966
100   $a19990924a19989999  s--            a
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aAngiogenesis weekly
210   $aAtlanta, GA $cNewsRx.com
311   $a1531-6416 
531 0 $aAngiogenes. wkly.
606   $aNeovascularization$vPeriodicals
606   $aBlood-vessels$xGrowth$vPeriodicals
606   $aCardiovascular pharmacology$vPeriodicals
606   $aTumor antigens$vPeriodicals
606   $aCardiovascular system$xDiseases$xTreatment$vPeriodicals
606   $aAntigens$vPeriodicals
606   $aAntigens$2fast$3(OCoLC)fst00810523
606   $aBlood-vessels$xGrowth$2fast$3(OCoLC)fst00834852
606   $aCardiovascular pharmacology$2fast$3(OCoLC)fst00847170
606   $aCardiovascular system$xDiseases$xTreatment$2fast$3(OCoLC)fst00847218
606   $aNeovascularization$2fast$3(OCoLC)fst01035916
606   $aTumor antigens$2fast$3(OCoLC)fst01158748
608   $aPeriodicals.$2fast
615  0$aNeovascularization
615  0$aBlood-vessels$xGrowth
615  0$aCardiovascular pharmacology
615  0$aTumor antigens
615  0$aCardiovascular system$xDiseases$xTreatment
615  0$aAntigens
615  7$aAntigens.
615  7$aBlood-vessels$xGrowth.
615  7$aCardiovascular pharmacology.
615  7$aCardiovascular system$xDiseases$xTreatment.
615  7$aNeovascularization.
615  7$aTumor antigens.
676   $a612
906   $aJOURNAL
912   $a996335979603316
996   $aAngiogenesis weekly$92396103
997   $aUNISA